|
Dr. Sattui’s work is focused on improving the care of patients living with vasculitis. His research is focused on the assessment of disease biomarkers and the treatment outcomes of patients living with vasculitis such as giant cell arteritis, ANCA-vasculitis, as well as polymyalgia rheumatica (PMR). He is also interested in aging-related outcomes of patients living with vasculitis and PMR, as well as other inflammatory conditions.
In response to the COVID-19 pandemic, Dr. Sattui also became involved in different COVID-19 related research initiatives including the COVID-19 Global Rheumatology Alliance. His work has focused on identifying the impact of COVID-19 on patients with rheumatic diseases as well the use of immunomodulatory therapy for the treatment of severe COVID-19.
|